Integra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins

Dow Jones

May 05

By Colin Kellaher

Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job.

Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO.

Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010.

The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board.

Integra said it doesn't plan to initiate a search for a new CEO.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

May 05, 2026 06:49 ET (10:49 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2633491197"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2633491197\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2633491197?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 18:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2633491197","market":"other","top_or_hot":-1,"title":"Integra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job. \n</p>\n<p>\n  Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO. \n</p>\n<p>\n  Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010. \n</p>\n<p>\n  The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board. \n</p>\n<p>\n  Integra said it doesn't plan to initiate a search for a new CEO. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 05, 2026 06:49 ET (10:49 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Integra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntegra LifeSciences Parts Ways With CEO Poul; Essig Retakes Reins\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-05 18:49</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job. \n</p>\n<p>\n  Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO. \n</p>\n<p>\n  Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010. \n</p>\n<p>\n  The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board. \n</p>\n<p>\n  Integra said it doesn't plan to initiate a search for a new CEO. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 05, 2026 06:49 ET (10:49 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2633491197","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2633491197","pubTimestamp":1777978140,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job.Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO.Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010.The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board.Integra said it doesn't plan to initiate a search for a new CEO.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","IART":"英特格拉生命科学"},"translate_title":"Integra LifeSciences与首席执行官Poul分道扬镳；醋夺回缰绳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IART":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Integra LifeSciences Holdings has parted ways with its president and chief executive, Mojdeh Poul, after a little more than a year on the job. \n\n\n  Integra on Tuesday said it has signed a separation agreement with Poul, who took the helm of the Princeton, N.J., medical-technology company in January 2025, and that its chairman, Stuart Essig, will once again serve as president and CEO. \n\n\n  Essig, who has been chairman since June 2012, previously served as Integra's CEO from 1997 through early 2012 and president from 1997 until 2010. \n\n\n  The company said Poul is entitled to payments and benefits related to a termination without cause, for good reason or due to non-renewal, adding that she has resigned from the board. \n\n\n  Integra said it doesn't plan to initiate a search for a new CEO. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 06:49 ET (10:49 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}